Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women

Amy C. Degnim, William D. Dupont, Derek C. Radisky, Robert A. Vierkant, Ryan D. Frank, Marlene H. Frost, Stacey J. Winham, Melinda E. Sanders, Jeffrey R. Smith, David L. Page, Tanya L. Hoskin, Celine M. Vachon, Karthik Ghosh, Tina J. Hieken, Lori A. Denison, Jodi M. Carter, Lynn C. Hartmann, Daniel W. Visscher

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

BACKGROUND: Women with atypical hyperplasia (AH) on breast biopsy have a substantially increased risk of breast cancer (BC). Here the BC risk for the extent and subtype of AH is reported for 2 separate cohorts. METHODS: All samples containing AH were included from 2 cohorts of women with benign breast disease (Mayo Clinic and Nashville). Histology review quantified the number of foci of atypical ductal hyperplasia (ADH) and atypical lobular hyperplasia (ALH). The BC risk was stratified for the number of AH foci within AH subtypes. RESULTS: The study included 708 Mayo AH subjects and 466 Nashville AH subjects. In the Mayo cohort, an increasing number of foci of AH was associated with a significant increase in the risk of BC both for ADH (relative risks of 2.61, 5.21, and 6.36 for 1, 2, and ≥ 3 foci, respectively; P for linear trend = .006) and for ALH (relative risks of 2.56, 3.50, and 6.79 for 1, 2, and ≥ 3 foci, respectively; P for linear trend = .001). In the Nashville cohort, the relative risks of BC for ADH were 2.70, 5.17, and 15.06 for 1, 2, and ≥ 3 foci, respectively (P for linear trend < .001); for ALH, the relative risks also increased but not significantly (2.61, 3.48, and 4.02, respectively; P = .148). When the Mayo and Nashville samples were combined, the risk increased significantly for 1, 2, and ≥ 3 foci: the relative risks were 2.65, 5.19, and 8.94, respectively, for ADH (P < .001) and 2.58, 3.49, and 4.97, respectively, for ALH (P = .001). CONCLUSIONS: In 2 independent cohort studies of benign breast disease, the extent of atypia stratified the long-term BC risk for ADH and ALH.

Original languageEnglish (US)
Pages (from-to)2971-2978
Number of pages8
JournalCancer
Volume122
Issue number19
DOIs
StatePublished - 2016

Keywords

  • Atypical ductal hyperplasia
  • Atypical hyperplasia
  • Atypical lobular hyperplasia
  • Breast cancer
  • Risk

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women'. Together they form a unique fingerprint.

Cite this